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Introduction: Current severity-of-illness indexes are unable to assess the long-term prognosis of patients requiring
prolonged mechanical ventilation. A prognostic scoring system (Prognosis for Prolonged Ventilation score - ProVent - score)
seems able to evaluate one-year mortality of such patients. However, testing of the model outside the developers' centers
has not been reported. So, it is unclear how the ProVent score performs in non-US and non-tertiary ICUs. The goal of our
study was to evaluate its performances in a French multicenter, community hospital-based setting.
Methods: In three primary ICUs, 201 patients requiring mechanical ventilation for at least 21 days were enrolled in a
retrospective cohort study. ICU mortality was abstracted from medical records and, for patients discharged alive from the
ICU, one-year mortality was determined by telephone calls to patients’ general practitioners.
Results: One-year mortality was 60% (n = 120). On day 21 of ventilation, ProVent score value was 0 in 19 patients (9%), 1 in
63 patients (31%), 2 in 64 patients (32%), 3 in 37 patients (18%), and ≥4 in 18 patients (9%), respectively. For ProVent score
values ranging from 0 to ≥4, one-year mortality rates were 21%, 43%, 67%, 78%, and 94%, respectively. The area under the
curve (AUC) of the receiver operator characteristic (ROC) curve for the ProVent score was 0.74 (95% confidence interval 0.671
to 0.809). Stepwise logistic regression analysis showed that only three variables (age ≥65 years, vasopressors, and
hemodialysis) were independently associated with one-year mortality in our population. In assigning one point to
each variable, we created a French ProVent score. The Hosmer-Lemeshow goodness-of-fit statistic was 1.36 (DF = 6,
P = 0.857) and the AUC of the ROC curve was 0.742 (95% confidence interval 0.673 to 0.810). One-year mortality rates
for French ProVent score ranging from 0 to 3 were 34.6%, 70.9%, 83.3% and 100%, respectively (P <0.0001).
Conclusions: The ProVent score is able, even in non-US ICUs and in community hospitals, to accurately identify among
patients requiring prolonged mechanical ventilation those who are at high risk of one-year mortality. Its simplification
appears possible. However, further validation of this French ProVent score in a larger external sample is indicated.Introduction
Mechanical ventilation is the most frequent invasive tech-
nique applied to patients admitted to the intensive care
unit (ICU). In the Extended Prevalence of Infection in
Intensive Care (EPIC II) study, including 14,414 patients
in 1,265 participating ICUs from 75 countries, more than
half of the patients required acute mechanical ventilation
during their ICU stay [1]. Among these mechanically
ventilated patients, the National Association for Medical
Direction of Respiratory Care estimated that 3 to 7%* Correspondence: oleroy@ch-tourcoing.fr
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unless otherwise stated.require prolonged mechanical ventilation defined as at
least 21 days [2].
Such patients pose numerous problems. The con-
sumption of a high amount of health-care resources, the
high ICU and long-term mortality rates, and the diffi-
culty to assess long-term prognosis must be underlined.
Concerning this later point, Carson and Bach demon-
strated in 2001 the inability of current severity-of-illness
indexes such as acute physiology and chronic health
evaluation score II, logistic organ dysfunction score,
mortality prediction model II, and simplified acute
physiology score II (SAPS II) to predict mortality of
patients suffering from prolonged critical illness [3].
Conversely, Carson et al. demonstrated that a prognostictd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ProVent - score) was able to evaluate one-year mortality
of patients requiring prolonged mechanical ventilation
after initial intubation in tertiary care medical centers in
the United States (US) [4,5]. However, it is unclear how
the ProVent score performs in non-US and non-tertiary
ICUs since, to the best of our knowledge, testing of the
model outside the developers' centers has not been
reported.
The goal of our study was to evaluate, in three French
community hospitals, the performances of the ProVent
score in a cohort of patients requiring prolonged me-
chanical ventilation in the ICU.
Material and methods
Patients
Patients were retrospectively enrolled between 1 January
2009 and 31 December 2011 from three primary ICUs
of community hospitals (Lens, Maubeuge, and Tourcoing)
in Nord-Pas de Calais, an area in the North of France.
Lens, Maubeuge and Tourcoing hospitals were 1091-bed,
390-bed and 456-bed primary care medico-surgical
centers with 16, 8 and 16 adult intensive care units
beds, respectively. Institutional ethics approval was
obtained from the Ethics Committee of Tourcoing Hos-
pital (N°2013-01) as the responsible ethics committee.
The Lens and Maubeuge institutional review boards
were contacted and gave ethical approval for study par-
ticipation. In accordance with French law, the need for
informed patient consent was waived in our study because
it is an observational retrospective cohort study that did
not modify existing diagnosis or therapeutic strategies.
Inclusion criterion was duration of mechanical ventila-
tion, after initial intubation, for at least 21 days during
ICU stay. Exclusion criteria were age <18 years old,
acute or chronic neuromuscular diseases, chronic dis-
eases requiring invasive mechanical ventilation before
ICU admission, and lack of data about patient characte-
ristics or outcome.
Data collection
In each site, cases were identified using a medical data-
base query on the duration of mechanical ventilation.
Data were retrospectively abstracted from medical
records by the principal investigator at each site (DT, FL,
and OL) and one abstractor who was blinded to patient
outcome (GL).
Variables collected on ICU admission were age, gen-
der, comorbidities, premorbid functional status (Knaus
chronic health status score), admission diagnoses, and
severity of illness (SAPS II, and sequential organ failure
assessment (SOFA)) [6-8]. Chronic cardiac diseases in-
cluded coronary heart diseases and heart failure (New York
Heart Association class III to IV). Chronic obstructivepulmonary diseases were defined according to criteria
proposed by the American Thoracic Society [9].
Chronic renal insufficiency was defined as a glomeru-
lar filtration rate <60 mL/min/1.73 m2 [10]. Immuno-
suppression was defined by administration of steroid
treatment in the six months prior to ICU admission (at
least 0.3 mg/kg per day of a prednisolone equivalent for at
least one month), and chemotherapy and/or radiotherapy
in the six months prior to ICU admission.
On day 21 of mechanical ventilation, platelet count,
and requirement of renal replacement therapy (on or
within 48 hours of this day), and vasopressors were
collected. In hospital outcome variables such as duration
of mechanical ventilation, weaning from mechanical
ventilation, tracheostomy during ICU stay, ICU length
of stay, decision to withdraw and/or withhold life
support, and ICU mortality were assessed. Finally, for
patients discharged alive from ICU, one-year mortality
was evaluated 12 months after day 21 of mechanical
ventilation, and was determined by telephone calls to
patients’ general practitioners.
ProVent score was determined for each patient as it
was described by Carson et al. [5]. Briefly, this score is
based on five predictor variables collected on day 21 of
mechanical ventilation. Predictors and their point sco-
ring system are age 50 to 64 years (+1 point), age
≥65 yrs (+2 points), platelet count <150 × 109/L (+1
point), use of vasopressors (+1 point), and requirement
for renal replacement therapy (+1 point). In adding the
points, we obtain the ProVent score.
Statistical analysis
Descriptive analyses were performed to check and resume
data. Quantitative variables are reported as means ± standard
deviation (SD). Qualitative variables are reported as number
and percentage.
First, ProVent score was computed using point scoring
derived from the β values provided by Carson et al. [5]
and previously reported as follows: age 50 to 64 years
(+1 point), age ≥65 yrs (+2 points), platelet count <150 ×
109/L (+1 point), use of vasopressors (+1 point), and
requirement for renal replacement therapy (+1 point).
Second, we included the five predictor variables in a
logistic regression model and assigned points to each
predictor variable according to the β coefficients found
in the model applied to our population. The Hosmer-
Lemeshow goodness-of-fit statistic was used to assess
the model.
Third, a stepwise logistic regression was used to select
the best subset of independent variables and compute a
French ProVent score. The Hosmer-Lemeshow goodness-
of-fit statistic was also used to assess the model.
Predictive capabilities of the ProVent score using the
point scoring as initially described by Carson et al., the
Table 1 Patient characteristics and outcome
Patient characteristics n = 201
Age, mean ± SD, years 64 ± 14
Male, n (%) 136 (68%)
Comorbidities, n (%)
Chronic cardiac diseases 122 (61%)
Chronic respiratory diseases 78 (39%)
Chronic endocrine diseases 59 (29%)
Chronic hepatic diseases 31 (15%)
Chronic neurologic diseases 33 (16%)
Chronic renal insufficiency 14 (7%)
Immunosuppression 9 (4%)
Malignancy 21 (10%)
Human immunodeficiency virus infection 5 (2.5%)
Knaus chronic health status score
Class A 32 (16%)
Class B 73 (36%)
Class C 64 (32%)
Class D 18 (9%)
Nonassessable 14 (7%)
ICU admission diagnoses, n (%)
Cardiovascular including septic shock 68 (34%)
Surgery 46 (23%)






Hematologic or malignancy 0 (0%)
SAPS II ICU admission, mean ± SD 51 ± 17
SOFA ICU admission, mean ± SD 9 ± 4
Hospital outcomes
Duration of MV, mean ± SD, days 37 ± 20
Duration of MV if died in ICU, mean ± SD, days 23 ± 29
Weaning from MV, n (%) 104 (52%)
Tracheostomy during ICU stay, n (%) 61 (30%)
ICU length of stay, mean ± SD, days 41 ± 21
Death in ICU, n (%) 83 (41%)
One-year mortality, n (%) 120 (60%)
SD, standard deviation; MV, mechanical ventilation; ICU, intensive care unit;
SAPS, simplified acute physiology score; SOFA, sequential organ
failure assessment.
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population, and, finally, the French ProVent score were
compared using receiver operator characteristic (ROC)
curves and area under the curve (AUC).
One-year survival curves were computed using the
Kaplan-Meier estimates. Comparisons of survival curves
according to the ProVent score were performed using
the log-rank test.
Data were analyzed using the SAS software V9.3 (SAS
Institute Inc., Cary, NC, USA).
Results
A total of 246 medical records of patients requiring pro-
longed mechanical ventilation were studied. According
to exclusion criteria (acute or chronic neuromuscular
diseases n = 4, chronic diseases requiring invasive me-
chanical ventilation before ICU admission n = 7, and lack
of data about patient characteristics n = 17 or outcomes
n = 17), 45 patients were not enrolled.
Characteristics and outcomes of the remaining 201 pa-
tients are summarized in Table 1. Underlying comorbidi-
ties were present in 179 patients (89%). Two-thirds of
patients were in class B or C of Knaus chronic health
status score. Most patients (n = 150; 74%) exhibited a
medical ICU admission diagnosis, mainly due to a
cardiovascular or pulmonary disease.
Mean duration of mechanical ventilation was 37 ±
20 days. Liberation from mechanical ventilation was not
obtained for 14 patients who were discharged from the
ICU. Eighty-three (41%) patients died in the ICU. A de-
cision to withdraw and/or withhold life support was
made for 71 of 83 patients who died in the ICU. Among
the 118 patients discharged alive from the ICU, 37 died
during the year following discharge. So, one-year morta-
lity was 60% (n = 120). The mean duration of survival
following ICU discharge was 190 ± 289 days.
On day 21 of mechanical ventilation, 76 (37.8%) pa-
tients were 50 to 64 years old, 88 (43.8%) were ≥65 years
old, 44 (21.9%) exhibited a platelet count <150 × 109/L,
43 (21.4%) required vasopressors, and 40 (20%) required
renal replacement therapy.
The number of patients included in the five groups (0
to ≥4) of the ProVent score and the one-year mortality
rates for score values ranging from 0 to ≥4, in our study
and in the second Carson’s study [5], were reported in
Table 2. One-year mortality rates for ProVent score
values ranging from 0 to ≥4, in our study and in Carson’s
study, were not statistically different.
One-year survival curves, according to the values of
ProVent score, are showed in Figure 1. Survival curves
were statistically different (log-rank test: P <0.0001).
The results of the logistic regression model applied to
our population are reported in Table 3. The analysis of
this model suggests that, in our population, age 50 to64 years and platelets ≤150 × 109/L were not inde-
pendently associated with one-year mortality and that,
according to the β values observed in our population,
a point scoring different from the point scoring reported by
Table 2 ProVent score and observed one-year mortality in Carson’s study [5] and our series
ProVent
score
Carson’s study (5) Our series
No. Observed mortality percent
(95% confidence interval)
No. Observed mortality percent
(95% confidence interval)
P*
0 72 20 (10-29) 19 21 (6-46) 0.9087
1 60 36 (24-48) 63 43 (30-56) 0.2568
2 78 56 (45-68) 64 67 (54-78) 0.0714
3 36 81 (67-94) 37 78 (62-90) 0.6844
4 or 5 14 100 (77-100) 18 94 (73-100) 0.0521
*Comparison between observed one-year mortality rates.
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3 points; platelets ≤150 x 109/L = 1 point; vasopressors = 2
points and hemodialysis = 2 points. The Hosmer-Lemeshow
goodness-of-fit statistic was 2.31 (DF = 6, P= 0.889).
Stepwise logistic regression analysis showed that only
three variables (age ≥65 yrs., vasopressors, and hemodialysis)
were independently associated with one-year mortality
(Table 4). A final model was computed using only
those three significant variables (Table 4). According
to the β values observed in this model, one point was
assigned to each variable to generate a French ProVent
score. The Hosmer-Lemeshow goodness-of-fit statistic
was 1.36 (DF = 6, P = 0.857). On day 21 of mechanical
ventilation, the number of patients with a French
ProVent score equal to 0, 1, 2 and 3 was 81, 79, 30 and
11, respectively. One year mortality rates for French
ProVent score ranging from 0 to 3 were 34.6%, 70.9%,
83.3% and 100%, respectively (P <0.0001).
The AUC of the ROC curves for the ProVent score
using point scoring reported by Carson et al., and point
scoring proposed by our analysis are 0.74 (95% confidenceFigure 1 Kaplan-Meier curve of one-year survival for patients by ProVe
Y axis: percentage of survival.interval 0.671 to 0.809) and 0.749 (95% confidence interval
0.680 to 0.817), respectively. The French ProVent score
has an AUC of the ROC curve of 0.742 (95% confidence
interval 0.673 to 0.810).
Discussion
The main results of this multicenter study provide vali-
dation of the ProVent score in a country other than the
USA and in primary ICUs of community hospitals.
Furthermore, our data suggest that this score could be
simplified.
Carson et al. demonstrated that four variables col-
lected in day 21 of mechanical ventilation were inde-
pendent predictors of one-year mortality of patients
requiring prolonged mechanical ventilation [4]. These
variables were age ≥50 years, requirement for vasopres-
sors, hemodialysis, platelet count ≤150 × 109/L. In a sec-
ond study, they built a prognostic scoring rule based on
the same risk variables but with two cut points for age.
A point value was assigned to each of the five risk vari-
ables. The ProVent score was obtained by adding pointsnt score. X axis: number of days after day 21 of mechanical ventilation.






Age ≥65 years 4.495 1.872-10.791 1.5029 0.0008
Age 50-64 years 1.134 0.488-2.638 0.1259 0.7700
Platelets ≤150 × 109/L 1.650 0.731-3.725 0.5007 0.2282
Vasopressors 3.326 1.355-8.163 1.2018 0.0087
Hemodialysis 3.410 1.278-9.102 1.2268 0.0143
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tality rates were 48% and 60%, respectively. Comparison
of mortality rates for ProVent score values ranging from
0 to ≥4, in these two studies, demonstrated no signifi-
cant difference. The AUC of the ROC curve for the Pro-
Vent score was 0.74 in our series and 0.76 in the Carson
et al. study [5]. Such data suggest that the ProVent score
performs well in our series in identifying patients at low-
est and highest risk of one-year mortality and, thus, that
ProVent score could be used in countries other than the
USA and in primary ICUs of community hospitals. Even
if our results could suggest that a point scoring different
from the initial point scoring reported by Carson et al.
could be proposed, the values of the respective AUC of
the ROC curves are quite similar, emphasizing the
robustness of the ProVent model.
The results of the stepwise logistic regression analysis
showed that in our series only three variables (age ≥65 yrs.,
vasopressors, and hemodialysis) were independently associ-
ated with one-year mortality. Two risk variables, age 50 to
64 years and platelet count ≤150 × 109/L, were not signifi-
cantly associated with one-year mortality. In our opinion,
such a result is not surprising. In fact, in the Carson et al.
study, the results of the logistic regression model already
showed that the independent prognostic value of age 50 to
64 years and platelet count ≤150 × 109/L could be ques-
tionable since odds ratios and 95% confidence intervals
were 2.0 (1.0 to 3.9) and 1.9 (0.9 to 3.9), respectively [5]. In
our study, in assigning one point to each risk variable we
created a French ProVent score able to stratify the one-
year prognostic of patients on day 21 of mechanical venti-
lation. Patients with a French ProVent score equal to 0, 1,
2 and 3 exhibited a significant increasing one-year mortal-
ity rate (34.6%, 70.9%, 83.3% and 100%, respectively). Of
course, further validation of this French ProVent score in a
larger external sample is indicated.Table 4 Model with three variables
Categorical
variable
Odds ratio 95% Confidence
interval
β Value P
Age ≥65 yrs 4.179 2.164-8.072 1.4302 <0.0001
Vasopressors 3.443 1.416-8.374 1.2365 0.0064
Hemodialysis 3.475 1.307-9.242 1.2456 0.0126Long-term prognostication of patients requiring pro-
longed mechanical ventilation is challenging. Current
severity-of-illness indexes are unable to predict mortality
of patients suffering from prolonged critical illness [3].
Conversely, ProVent score appears as a simple, impartial
and reproducible score able to accurately identify among
patients requiring prolonged mechanical ventilation those
who are at low or, conversely, at high risk of one-year
mortality. However, the impact of the ProVent score on
patient care and information given to patients, families,
and surrogate decision makers remains to be determined.
In our study, as in study of Carson et al., the score was
not used for decisions of withholding or withdrawing life-
sustaining treatment and communication with families. In
our series, the decision to withdraw or withhold life sup-
port was made for 86% of patients who died in the ICU,
but the ProVent score was never calculated before this
decision. The two most important factors influencing
decisions to withdraw or withhold life support are patient
preferences and patient prognosis [11,12]. The use of a
simple and reproducible score such as the ProVent score
to give physicians reliable prognostic information could be
interesting. Nevertheless, we must bear in mind the two
following points: most often, physicians do not take into
account prognostic information given by prognostic
models, as demonstrated by the SUPPORT study [13].
Second, the translation of data from population-level
outcomes to individual risk estimation has inherent
limitations. Consequently, according to current ethical
standards, the use of scoring systems as a unique tool
to guide decisions of withdrawing or withholding life
support is inappropriate [14].
Our study has several limitations and weaknesses. Briefly,
it was a retrospective study. This point explains that 15%
of studied patients were not enrolled in the cohort and that
long-term functional status was not assessed. For the same
reason, the impact of the ProVent score values on patient’s
care and information given to patients, families, and surro-
gate decision makers was not studied. This later point is a
major drawback of our study but represents a goal for
future studies. Paired with clinical judgment, original or
French ProVent scores should be evaluated, in futures
studies, as a piece of the decision support process accep-
table for physicians, patients and their family.
Conclusions
The ProVent score could be used in countries other
than the US and in primary ICUs of community hospi-
tals. It appears as a simple, impartial and reproducible
score able to accurately identify among patients requi-
ring prolonged mechanical ventilation those who are at
high risk of one-year mortality. Its simplification appears
possible. However, further validation of this French Pro-
Vent score in a larger external sample is indicated.
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information given to patients and family remains to be
studied.
Key messages
 The ProVent score is able to evaluate one-year
mortality of patients requiring prolonged mechanical
ventilation after initial intubation.
 It can be used in countries other than the US and
in primary ICUs of community hospitals.
 A French ProVent score based on three predictors
(age ≥65 years, vasopressors, and hemodialysis)
performs as well as the original ProVent score.
 The impact of these scores on patient care and
information given to patients and family remains
to be studied.
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